All News

Anticoagulation briefs.

Will the DEA finally reclassify marijuana to schedule 2?

Patents expire, competition rises, and outsourcing expands.

The CREATES Act came about because some pharmaceutical manufacturers are misusing the REMS program to prevent generic drug development.

Really? Still? Why?

Update: LABA/LAMA combo therapies

As the opioid epidemic continues to get worse, some health insurers are blocking patients identified as “high risk” from getting multiple opioid prescriptions filled at various pharmacies by restricting where they can fill prescriptions.

David H. Kreling, PhD, a professor at the School of Pharmacy, University of Wisconsin, Madison, and the principal investigator for the ADI project for the Midwest Pharmacy Workforce Consortium, thinks a surplus of pharmacists could spur positive change.

Pharmacist Maisha McCoy will never forget those tense days in late April 2015, when rioting and looting were widespread throughout Baltimore.

Nine patients at Birmingham-area hospitals developed bloodstream infections and died after receiving TPN compounded by Meds IV.

The pharmacy school would be the second in the state.

The culture shock between pharmacy school and the real world is mind-boggling.

A 60-year debate accompanied the elevation of pharmacy education to the doctoral level. When the provider status bill now moving through Congress is enacted into law, it will put paid to that particular conversation.

Bruce Kneeland is on the hunt for unique indie pharmacies across the country.

FIP's 76th annual World Congress of Pharmacy and Pharmaceutical Sciences takes place in Buenos Aires in August. This year's topic: The global disease burden.

Rolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.

The guidelines, which update the group's 2007 and 2009 recommendations, are published in the "Annals of Internal Medicine."

CVS decided to abandon tobacco sales in 2014. Plenty of community pharmacists were way ahead on that one.

APhA has announced its new officers for 2017-2018.

An expert with 35 years' academic and professional experience calls it like he sees it.

According to PBMs, those drug coupons are something else.

More than 300 pharmacists turned out to support H.R. 244, the “MAC Transparency Act," and H.R. 793, the “Ensuring Seniors Access to Local Pharmacies Act of 2015.”

A Danish study has found a possibility of increased risk of miscarriage in pregnant women who use oral fluconazole to treat yeast infections.

The movement to get naloxone into the hands of first responders, drug users, and their family members has found increasing support in state legislatures.

Most pharmacy shelves stock numerous alternative treatments for simple skin problems. Here are a few of the newer ones.

FDA approves a new indication, then issues strengthened warning about possible effects.

New Rx, indications, generics, and OTC

Physicians have been called "Doc" for so long that the terms are essentially identical. Why not designate pharmacists by a separate and distinct title?